Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EyePoint, Inc.EYPT · Entity 5702 | See Remarks | June 27, 2019 | June 28, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EyePoint, Inc.
Report date June 27, 2019 · Filed June 28, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,044 |
Ending reported balance
After 2019-06-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-06-27 · Exercise / conversion · Acquired 6,667 · Balance 92,005 F1: Restricted stock units convert into common stock on a one-for-one basis. Row 2 · 2019-06-27 · Tax withholding · Disposed 1,961 · Balance 90,044 F2: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 6,667 |
Reported balance
After 2019-06-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-06-27 · Exercise / conversion · Disposed 6,667 · Balance 6,667 F3: On June 27, 2017, the reporting person was granted 20,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
F3: On June 27, 2017, the reporting person was granted 20,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 27, 2019 Filed Jun 28, 2019 17:04 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 6,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003677 · primarydocument.xml · derivative · entry 3 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 6,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On June 27, 2017, the reporting person was granted 20,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 27, 2017, the reporting person was granted 20,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 27, 2019 Filed Jun 28, 2019 17:04 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,961 | $1.65 | $3,235.65 |
DisclosureSEC source: 0001562180-19-003677 · primarydocument.xml · nonDerivative · entry 2 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,044 F2 · shares: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 27, 2019 Filed Jun 28, 2019 17:04 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003677 · primarydocument.xml · nonDerivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 17:41 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 8,280 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003561 · primarydocument.xml · derivative · entry 3 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,560 Underlying: Common Stock · 8,280 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On June 14, 2018, the reporting person was granted 24,840 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 14, 2018, the reporting person was granted 24,840 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 17:41 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 2,394 | $1.53 | $3,662.82 |
DisclosureSEC source: 0001562180-19-003561 · primarydocument.xml · nonDerivative · entry 2 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,338 F2 · shares: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 17:41 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 8,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-003561 · primarydocument.xml · nonDerivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 08:24 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001562180-19-002080 · primarydocument.xml · derivative · entry 2 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2019-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was granted on 6/25/2009 and vested in four equal annual installments beginning on the first anniversary of the grant. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 08:24 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 5,000 | $1.81 | $9,050.00 |
DisclosureSEC source: 0001562180-19-002080 · primarydocument.xml · nonDerivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 17:22 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,735 | $2.47 | $4,285.45 |
DisclosureSEC source: 0001562180-19-002006 · primarydocument.xml · nonDerivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,452 F1 · shares: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units F2 · price: Reflects the last reported sale price for the Registrant's shares of common stock on the Nasdaq Global Market on March 19, 2019 Read SEC document |
| December 22, 2018 Filed Dec 26, 2018 16:06 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted stock units · Derivative | 62,892 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-031698 · doc4.xml · derivative · entry 3 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,892 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 22, 2017, the reporting person was granted 62,892 restricted stock units, vesting in full on the first anniversary of the grant date. F4 · derivative.expiration_date: On December 22, 2017, the reporting person was granted 62,892 restricted stock units, vesting in full on the first anniversary of the grant date. Read SEC document |
| December 22, 2018 Filed Dec 26, 2018 16:06 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 18,522 | $1.65 | $30,561.30 |
DisclosureSEC source: 0000899243-18-031698 · doc4.xml · nonDerivative · entry 2 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,187 F2 · shares: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units. F3 · price: Reflects the last reported sale price for the Registrant's shares of common stock on the Nasdaq Global Market on December 21, 2018. Read SEC document |
| December 22, 2018 Filed Dec 26, 2018 16:06 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 62,892 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-031698 · doc4.xml · nonDerivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 16:00 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 2,945 | $3.23 | $9,512.35 |
DisclosureSEC source: 0000899243-18-026782 · doc4.xml · nonDerivative · entry 2 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,817 F2 · shares: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the performance stock units. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 16:00 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-026782 · doc4.xml · nonDerivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,762 F1 · shares: On October 12, 2018 (the "FDA Approval Date"), the U.S. Food and Drug Administration approved EyePoint Pharmaceutical Inc.'s (the "Company") new drug application for YUTIQ for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. As a result, 10,000 shares representing a previously granted performance stock unit award vested on that date. An additional 10,000 shares from this award will vest on the first anniversary of the FDA Approval Date, subject to the Reporting Person's continued employment with the Company through the applicable vesting date. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 16:01 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 6,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-018711 · doc4.xml · derivative · entry 3 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,334 Underlying: Common Stock · 6,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On June 27, 2017, the reporting person was granted 20,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On June 27, 2017, the reporting person was granted 20,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 16:01 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,904 | $1.86 | $3,541.44 |
DisclosureSEC source: 0000899243-18-018711 · doc4.xml · nonDerivative · entry 2 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,762 F3 · shares: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the insider's exercise of his withholding right following the vesting of the restricted stock units. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 16:01 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 6,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-018711 · doc4.xml · nonDerivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 16:05 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (right to buy) · Derivative | 85,100 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0000899243-18-016975 · doc4.xml · derivative · entry 2 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,100 Underlying: Common Stock · 85,100 shares Expires 2028-06-14 F3 · derivative.exercise_date: The option to purchase will vest and become exercisable in three equal annual installments beginning June 14, 2019. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 16:05 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 21,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-016975 · doc4.xml · derivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,300 Underlying: Common Stock · 21,300 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: The restricted stock units will vest in three equal annual installments beginning June 14, 2019. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. F2 · derivative.expiration_date: The restricted stock units will vest in three equal annual installments beginning June 14, 2019. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. Read SEC document |
| June 14, 2018 Filed Jun 22, 2018 16:00 UTC Amendment | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (right to buy) · Derivative | 99,360 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0000899243-18-017684 · doc4a.xml · derivative · entry 2 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,360 Underlying: Common Stock · 99,360 shares Expires 2028-06-14 F3 · derivative.exercise_date: The option to purchase will vest and become exercisable in three equal annual installments beginning June 14, 2019. Read SEC document |
| June 14, 2018 Filed Jun 22, 2018 16:00 UTC Amendment | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 24,840 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-017684 · doc4a.xml · derivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,840 Underlying: Common Stock · 24,840 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: The restricted stock units will vest in three equal annual installments beginning June 14, 2019. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. F2 · derivative.expiration_date: The restricted stock units will vest in three equal annual installments beginning June 14, 2019. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 16:00 UTC | EyePoint, Inc. PSDV · Entity 5702 | GrantCommon stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-008243 · doc4.xml · nonDerivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: On March 19, 2018 (the "NDA Acceptance Date"), the U.S. Food and Drug Administration ("FDA") accepted pSivida Corp.'s (the "Company") new drug application for Durasert 3-year treatment for posterior segment uveitis. As a result, 5,000 shares representing a previously granted performance stock unit award vested on that date. An additional 5,000 shares from this award will vest on the first anniversary of the NDA Acceptance Date, subject to the Reporting Person's continued employment with the Company through the applicable vesting date. Read SEC document |
| December 22, 2017 Filed Dec 27, 2017 16:05 UTC | EyePoint, Inc. PSDV · Entity 5702 | GrantRestricted Stock Units · Derivative | 62,892 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-029611 · doc4.xml · derivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,892 Underlying: Common Stock · 62,892 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: The restricted stock units will vest in full on December 22, 2018 and the vested shares will be delivered to the reporting person within 30 days following the vesting date. F2 · derivative.expiration_date: The restricted stock units will vest in full on December 22, 2018 and the vested shares will be delivered to the reporting person within 30 days following the vesting date. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 15:58 UTC | EyePoint, Inc. PSDV · Entity 5702 | GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0000899243-17-017515 · doc4.xml · derivative · entry 2 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-06-27 F3 · derivative.exercise_date: The option to purchase will vest and become exercisable in three equal annual installments beginning June 27, 2018. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 15:58 UTC | EyePoint, Inc. PSDV · Entity 5702 | GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-017515 · doc4.xml · derivative · entry 1 Ross Leonard S · CIK 0001458753 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: The restricted stock units will vest in three equal annual installments beginning June 27, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. F2 · derivative.expiration_date: The restricted stock units will vest in three equal annual installments beginning June 27, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.